XTL BIOPHARMACEUTICALS LTD. Additional Recognition Goodwill
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Additional Recognition Goodwill of $3.60 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:AdditionalRecognitionGoodwill · last filed 2025-04-30
| Period end | Additional Recognition Goodwill 12 month |
|---|---|
| 2024-12-31 | $3.60M 20-F · filed 2025-04-30 |